Dr. Joseph Rossi Berger, MD

Dr. Berger practices at Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health.

Dr. Berger's NPI, 1659573475, was assigned on June 4, 2007. Dr. Berger graduated from UT Southwestern Medical Center in 2004. Dr. Berger's Texas license number on file is M9855.

Dr. Berger's primary practice is Parkland Memorial Hospital, at 5200 Harry Hines Blvd, Dallas, TX 75235 in Dallas County. The practice phone is (214) 590-8000.

Dr. Berger's primary practice is Parkland Memorial Hospital in Dallas, Texas, part of Parkland Health. Dr. Berger is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Berger to 1 more clinical lab, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berger practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Berger's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Berger is board certified in geriatric medicine by the American Board of Internal Medicine. Dr. Berger has a license on file in Texas.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Berger treats.

CMS data shows 344 Medicare services from Dr. Berger across 5 procedure codes in 2024, for 142 Medicare patients. Medicare paid $23,865 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 142 Medicare patients who saw Dr. Berger in 2024. The largest group is under 65, with 76 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 50% are also on Medicaid. Their average risk score is 6.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berger's median patient age at 60, with 44% women.

In 2024, Dr. Berger wrote 162 Medicare Part D claims for 28 patients. 76% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $317 in total drug cost. In 2023, CMS named 160 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Berger for performance year 2024, reported as part of a group. Dr. Berger accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 119 papers to Dr. Berger, published from 2010 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Leukoencephalopathy, Progressive Multifocal, Multiple Sclerosis and JC Virus. Dr. Berger has published most often in J Neurovirol. Dr. Berger's most frequent co-authors are Clyde E. Markowitz, MD, Salim Chahin, MD and Bruce A. Cree, MD.

CMS Open Payments shows 2 general payments to Dr. Berger from 2 drug and device companies from 2017 to 2021. Consulting fees make up the largest share, 99% of the total. Bristol-Myers Squibb Company paid the most, $1,000.

Dr. Berger graduated from UT Southwestern Medical Center in 2004.

Dr. Berger is in network with 18 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.